Release of suit against AngioDynamics was not declared by a Delaware district court judge over patents for devices installed below the skin for effortlessness drug delivery. C.R. Bard Inc. stated that AngioDynamics had infringed on patents issued in 2013 and 2014 and AngioDynamics further added the claims as ineligible to be patented due to loss of description of specific items that can be patented [more].
top of page
Search
Recent Posts
See AllGeneral Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
bottom of page
Comments